Disc Medicine market cap IRON
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Nov 2, 2026
- $3B
- Highest close in our data
- $3.5B
- Nov 2025
Disc Medicine is worth $3B at the close on Nov 2, 2026, at $78.62 a share.
That is down 5% over the last year and up 1772% over five years.
Its highest close in our data was $3.5B in Nov 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3B | $2.1B | $3.1B | −0% |
| 2025 | $3B | $1.3B | $3.5B | +59% |
| 2024 | $1.9B | $680M | $1.9B | +37% |
| 2023 | $1.4B | $82.2M | $1.5B | +1518% |
| 2022 | $86.2M | $54.5M | $109.9M | −31% |
| 2021 | $125.5M | $103M | $570.2M | −27% |
| 2020 | $170.9M | $156.1M | $170.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Disc Medicine's size, closest first, today.
| Company | Market cap |
|---|---|
| IRONDisc Medicine | $3B |
| NRIXNurix Therapeutics | $2.8B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.7B |
| PBHPrestige Consumer Healthcare | $2.4B |
| ARQTArcutis Biotherapeutics | $3.9B |
| HRMYHarmony Biosciences | $2.2B |
| INDVIndivior Pharmaceuticals | $4.3B |
| ANIPANI Pharmaceuticals | $1.6B |
| PAHCPhibro Animal Health | $1.6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| Peer median | $3.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Disc Medicine
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.